0001193125-22-158660.txt : 20220623 0001193125-22-158660.hdr.sgml : 20220623 20220524172435 ACCESSION NUMBER: 0001193125-22-158660 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20220524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 CORRESP 1 filename1.htm CORRESP

LOGO

 

Wilson Sonsini Goodrich & Rosati

Professional Corporation

650 Page Mill Road

Palo Alto, California 94304-1050

O: 650.493.9300

F: 650.493.6811

May 24, 2022

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention:     Daniel Crawford

 

Re:    ALX Oncology Holdings, Inc.
   Registration Statement on Form S-3
   Filed March 25, 2022, Amended on May 13, 2022
   File No. 333-263863   
   Acceleration Request   
   Requested Date:    May 25, 2022
   Requested Time:    4:05 p.m. Eastern Time,
      or as soon thereafter as practicable

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, ALX Oncology Holdings, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-263863) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Michael E. Coke at (650) 565-3596.

Please direct any questions or comments regarding this acceleration request to Michael E. Coke at (650) 565-3596.

[Signature Page Follows]

AUSTIN        BEIJING        BOSTON         BRUSSELS        HONG KONG        LONDON        LOS ANGELES        NEW YORK        PALO ALTO

SAN DIEGO        SAN FRANCISCO        SEATTLE        SHANGHAI        WASHINGTON, DC        WILMINGTON, DE

LOGO

Securities and Exchange Commission

May 24, 2022

Page 2

 

Sincerely,
ALX Oncology Holdings, Inc.
/s/ Peter Garcia
Peter Garcia
Chief Financial Officer

 

cc:

Michael E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation

Christina L. Poulsen, Wilson Sonsini Goodrich & Rosati, Professional Corporation

GRAPHIC 2 g293656dsp1.jpg GRAPHIC begin 644 g293656dsp1.jpg M_]C_X 02D9)1@ ! $ 8 !@ #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$ @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\< M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3H.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1 (! @0$ P0'!00$ $"=P ! @,1 M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_ !$( $8 G@,!$0 "$0$#$0'_V@ , M P$ A$#$0 _ /?Z "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@#SWXO7^M:1X;M=1T>[GMS%XU"TFQ(S\DHPRISC'4,,>WO15CRO0,/4*;VYTS5G33UN#]GC0$(T:G"D@\\@ GIR3TK:--6U.2=>;DVGH>Q^*_&$5 MG\-)O$%@6#7=NHMOF 9&DX!)&0"N2<>JXS6$8^]9G;4J6I\R.4^#NK>)=?O= M1OM4U.XN;"",1(LH^5I"0<@],@#D?[8JZJC'1&6&E.3;;T*'Q?\ %>O:%XMM M;72]3GM8&LDD9(R,%B[C/Y ?E3I136I.)J2C.T6>K>%[F:\\):-=7$ADGFLH M9)';JS% 2?SK&6C9UTW>";/%#XT\1CXM?V7_ &O);;PEX=N-6N$$OEX6.'>%,KDX"@G\2>O )QQ M41CS.QK4FJ<>9GA,?B7XB^.]08:7/> ;ON6),$47!(!?(QW^\W/Y5T\L(+4X M.>M5?ND$WBGX@>"M62#4;Z]$D;!S%>,9DD'3J);;Q9X=M]6MT$1DRLD.\,8G!P5)'X$=."#CFN:4>5V/0IS4X\R/&OB3 MXT\2:3X_U.QL-7N+>UB\K9&A&%S$A/ZDUT4X1<4VCBKU9QJ-)GJ7P\\8Q>+O M#D;2+K4DP8;:6.*0G3Y"/J157UL9J+:N: ME[XFEN_ VE>'07$=GZ>'CV2W6ZY;IR&/RGCU0+[_ ,JYJCO(]'#QY::/+_CK_P CO9?]@]/_ $9) M6U'X3DQ?QKT/:O!W_(D:!_V#[?\ ]%K7/+XF=U/X%Z'SX?\ DM__ ','_MQ7 M5_R[^1YW_+[Y_J?3M<9ZIRWC_P */XP\,-IT$T<5PDJS0M)G;N (YQ[,>QJX M2Y7$0SVD/F$O!<1$PR-TR#WSMZJ>0.N*Z6HS//C M*I19[!X ^)UKXPD:PNX$LM41050/E9\#YBF>A')V\G'!&N+78892H+1EI$!P>P M(X/_ -:BDVI"Q"3IMLY/X!7%P5URV.XVRF)QE_E1CN'"^I Y/^R/:M*W0QPC M>J.*^*XS\4=6!Z$P_P#HE*TI_ C#$?Q65-^L_#3QI(DDXD^]1F6(=5AUSXO:?JENI6.ZU.WD"MU7+ID'Z'BE:T+%*7-537='U M!7&>J% 'S+\6M&31_']VT*;(KU1= 9SRV0QZGJP8]NOI792=XGE8B/+4]3TG MP7X/:Y^#5UI=W;R1SZEYLPCD!1E?@1G!([HC>A^AK&CROJ>(^'= M)DUSQ%8:;&CN)YT1]BDE4R-S<=@,DGVKHD[*YP0CS22/K^N$]H^>_CK_ ,CO M9?\ 8/3_ -&25U4?A/-Q?QKT/:O!W_(D:!_V#[?_ -%K7/+XF=U/X%Z'S?K. MH?V3\4[_ %+RO-^R:P\_E[MN[;,6QGG&<=:ZTKPL>9)\M5OS/0?^%_\ _4L_ M^3W_ -KK+V/F=/UO^Z=E\3-9\2Z+H4,OARU9F9_W]RJJYA'& $(.=Q/7!QCW M!&=-1;U-Z\IQC[AYU%\;;^719;'5=!L[^>1"H=B5C;@8WQD'=SR<$ ].*U]B MKW3.58I\MI*Y!\&/#-]=^)X]>VB*SL-PRZL#*71UPO&#COZ<>M.K))6%AJ;< MN;L>H?$GP6OC#P__ *.I_M.SW/:G?M#9QN0YXY &.F"!R!G.-.?*SKKTO:1T MW/)_"'C_ %[P$KZ)>Z/-J9QTZTJ7N MM$/B?Q;XD^)5Y#I5II316JS*8[6-=Q$F" 7D(&.K>@ Z],TXQC#4*E2=9\J1 M[-X \&1^"] ^RNZ37T[>9Y)XSBN><^9G;1I>SC;J>'?%; M_DJ6J_6'_P!%)733^!'!B/XK/:OB+X(3QGHBK$Q34;3TCYGSWX21XO'>A1R*4==1@#*PP0?,7BNJ7PL\ZGI->I];5 MPGL!0 4 % !0 4 % !0 4 % !0!F7?AS0[^Z:YO-&L+BX;[TLMLCL>,C"VM;>RMU MM[6"."%<[8XT"J,G)P![DF@$DM$2T#"@ H * "@#B/BAXNNO"7AI)-/&+ZZE M\J*0@$1#&2V""#Z8/KGM@Z4X\SU,*]1TXZ;GBNE>"/%GC6TEUN+-WN.WSKBY M!>0J,8RQSQ@#G':NASC#0X(TJE1_WN M=OU_#BL*G+?W3MP_M+>^7_B/XZ'@S1X_LOER:I?0^UUG&5[GNMSXFM==^&VJZSI% MT0183'=&Q#PR",G'8A@@YJ5-RCV/./@QKVLZIXPNX-0U:] MNX5L7<)/,GI^&OM(MV.?V%1+F1[WX+_X2'_A&H/\ A)O*^W]MGWMF!CS. MV_.C2Y^7W]SR'4O$.MQ_&I+!-8OEL_[5AC\@7+B/:77*[< MXQ[5T**Y+V.*4Y>VM?J>H_$^\NM/^'>JW5EI M336AQT*[C*TGH>@?&35;S3_!=E=:7?SVSR7J#S;:8H64QN<94\C@&LJ23EJ= M.)DU!.+)?@WJ5]JG@ZXGU"]N+N87K*'GE9V V(<9)ZVM?J>_5S'HG+ M>/\ P@OC+PX;)91#=POYUNY P7 (VMWVG/;V/.,&X2Y7(I+XZ^% MDYC(DMK:8EMK8E@D/3(Z@-P/1L 9XKH]RHJ?#?XE2>,YY]/OK*.WOH M(O-WPD[)%W8/!^[C*]SG)Z5C4I\NJ.NA7]IHUJ>>?%K9+\4K>.Z;_1Q' K;F MP F>>>PY/ZUK2^#0YL1_%U/H"S^S?8H/L7E?9/+7R?)QLV8^7;CC&,8Q7*_, M]%6MH>6?'F*S/AS2YG*?;5NBL0+X;RRAWX7/(R(\G'''KSO1O=G)B[E61C%S--,4\QL#* M[FQG'H"*Z+\L;GGJ#G-Q1)X<\477ANWUK2YA+]DO[6:WEAVC*RE&56P>1@G! M]O7 %$HJ5F.%1PO%]3J?@3_R.][_ -@]_P#T9'45OA-<)\;]#O?BA\.[OQ>] MG?Z9-"EY;H8WCEX$B=1A@.H.>#QSU&.P()& ,<5MR0GJCE56K2T9[7X,\9V/C32GO+2&6" M2%@DT4F#M; /!'4=>>#QT%<\X.+L=U*JJBNCQ+5?^2\Q_P#88@_]#6NA?PSA ME_'^9Z[\6J6J;XM.:+SE'4* M^[YOH"HS]<] :ZG))I'FJ#<6UT-&\\87NH^!;?PW>D2)9W*26TAR6"!9 5)[ M@;EQZ 8],)12E=%.HW#D?0]A^!O_ "(]U_U_/_Z+CK"M\1VX7X/F>=ZG_P E MZ3_L,0_^AK6J_AG-+^/\SZ0KD/3.$^*K^)X_#*'PYYRJ)-UU);,1,J#IMQSC M/4CGCTS6E/EOJ<^(Y^7W#RH?%[Q;)I%Q8W4=I=K*C(\TMN0X##'\)"_3C\ZW M]E&]SD^L5+69O_ [PY?IJEQX@GM@E@8&@AD?J[[ER5'H ""??'/.)K25K&F% M@[\SV.M^*'P^?Q9:Q:CIJYU>W41A6?"RQY)V\\ @DD'CJ<]L9TY\NCV-J]'G M5UN>9:3\2_&/@^T&BSVR/]G 5(K^!Q)$N,A>"IQ@C&<\8QQBMG3C+4Y(UZE- M'="L]) ML\^3;)M!)Y8DY9OQ))_&N23N[GIPBH144>!_#S_DM,7_ %WNO_0'KJG\!YU' M^-]YUGQ@\ QR6TOB?2H'^T*_\ 8/?_ -&1U=;X3+"?&_0Z'XL:AXWTG6K?4-/N)H-'@ :)[3=M M#?+GSNQ^;@ \$''7-134&K/_LS4;&T2VF*G MSD@8,Q4]02Q'7K@>U:1IQB[HPG7G.-FCU3X0>&=4\.>'[IM4@^SR7DBRI$Q^ M=5V_Q#L?;KZXK&K)-Z'7AJE[-Z; M'IWP-X\#W7_7\_\ Z+CK&M\1UX7X/F>=ZGQ\>X_^PQ#_ .AK6J_AG-+^/\SZ M0KD/3"@"![*UDE:1[:%I&()8H"3CIS1<5D3T#"@"&XL[:ZV_:+>*;;]WS$#8 M^F:+V$TGN34#"@ H * "@ H JPZ;8V\HEALK>.0=&2)01^(%.[$HI;(M4AA0 .. 4 % !0 4 % !0!__]D! end GRAPHIC 3 g293656dsp1a.jpg GRAPHIC begin 644 g293656dsp1a.jpg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end